Lonza | LONN - Net Income


Lonza reported CHF426M in Net Income for its fiscal semester ending in June of 2025.





Net Income Change Date
Akzo Nobel EUR 93M 505M Mar/2026
Alcon AG USD 189M 28M Mar/2026
Almirall EUR 19.58M 7M Dec/2025
AstraZeneca USD 3.08B 754M Mar/2026
BASF EUR 927M 367M Mar/2026
Bayer EUR 2.76B 6.52B Mar/2026
Beiersdorf EUR 387M 165M Dec/2025
Covestro EUR -378M 331M Dec/2025
Demant DKK 427M 690M Dec/2025
Fresenius EUR 361M 17M Dec/2025
Fresenius Medical Care EUR 118M 209M Mar/2026
Geberit CHF 103.5M 52.3M Dec/2025
Genmab DKK 31M 370M Dec/2025
Givaudan CHF 479M 113M Dec/2025
GlaxoSmithKline GBP 1.74B 1.1B Mar/2026
GN Store Nord DKK -955M 1.3B Mar/2026
Hikma Pharmaceutical USD 164M 45M Dec/2025
Johnson Matthey GBP -78M 60M Jun/2026
Merck EUR 659M 340M Mar/2026
Novartis USD 3.16B 747M Mar/2026
Philips EUR 151M 244M Mar/2026
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR 1.61B 2.42B Mar/2026
Sika AG CHF 490.2M 63.6M Dec/2025
Smith & Nephew USD 293M 79M Dec/2025
Solvay EUR 26M 121M Mar/2026
UCB EUR 1.08B 608M Dec/2025